Dr. Harsh Singh
doctorMale0.0Global Dominance: 0.00%
Dr. Harsh Singh is affiliated with Mass General Brigham Cancer Institute, where he has acknowledged the clinical trial results of daraxonrasib as a groundbreaking advancement in the treatment of pancreatic cancer.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Dr. Harsh Singh from Mass General Brigham called the findings a landmark study in pancreatic cancer treatment.
"לא רואים דברים כאלה": הקהל הריע לתרופה הזוידיעות אחרונות (Yedioth Ahronoth / ynet)·
Israel· 2026-06-01
Israel· 2026-06-01
